Sanofi (Metoclopramide Product Portfolio) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Sanofi (Metoclopramide Product Portfolio) General Information

Description

A portfolio of metoclopramide products. The portfolio comprises the rights in Italy and 14 other countries internationally to the Plasil and Primperan brands.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Italy
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Corporate Office
  • Italy

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sanofi (Metoclopramide Product Portfolio) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sanofi (Metoclopramide Product Portfolio)‘s full profile, request access.

Request a free trial

Sanofi (Metoclopramide Product Portfolio) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sanofi (Metoclopramide Product Portfolio)‘s full profile, request access.

Request a free trial

Sanofi (Metoclopramide Product Portfolio) FAQs

  • Where is Sanofi (Metoclopramide Product Portfolio) headquartered?

    Sanofi (Metoclopramide Product Portfolio) is headquartered in Italy.

  • What industry is Sanofi (Metoclopramide Product Portfolio) in?

    Sanofi (Metoclopramide Product Portfolio)’s primary industry is Buildings and Property.

  • Is Sanofi (Metoclopramide Product Portfolio) a private or public company?

    Sanofi (Metoclopramide Product Portfolio) is a Private company.

  • What is Sanofi (Metoclopramide Product Portfolio)’s current revenue?

    The current revenue for Sanofi (Metoclopramide Product Portfolio) is .

  • Who are Sanofi (Metoclopramide Product Portfolio)’s investors?

    Sanofi has invested in Sanofi (Metoclopramide Product Portfolio).

  • When was Sanofi (Metoclopramide Product Portfolio) acquired?

    Sanofi (Metoclopramide Product Portfolio) was acquired on 01-Apr-2025.

  • Who acquired Sanofi (Metoclopramide Product Portfolio)?

    Sanofi (Metoclopramide Product Portfolio) was acquired by Neopharmed Gentili.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process